Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients

Erika Watanabe, Takuro Nishikawa, Kazuro Ikawa, Hiroki Yamaguchi, Takanari Abematsu, Shunsuke Nakagawa, Koichiro Kurauchi, Yuichi Kodama, Takayuki Tanabe, Yuichi Shinkoda, Kazuaki Matsumoto, Yasuhiro Okamoto, Yasuo Takeda, Yoshifumi Kawano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Optimizing systemic busulfan exposure, the area under the concentration–time curve (AUC), improves the outcomes for hematopoietic stem cell transplantation (HSCT). The AUC is conventionally calculated using six plasma concentrations (AUC0–∞) drawn after the first of 16 intravenous busulfan doses given as a 2-h infusion every 6 h. The aim of the present study was to develop limited sampling strategies using three or fewer busulfan concentrations to reliably calculate AUC0–∞ in patients undergoing HSCT. We investigated the pharmacokinetics of busulfan 46 times in 29 pediatric patients receiving intravenous busulfan. Limited sampling strategies using one, two, or three plasma busulfan concentrations were developed by multiple linear regression that showed excellent agreement with AUC0–∞. In single-point sampling strategies, the AUC0–∞ predicted based on C6 (trough level: busulfan plasma concentration 6 h after the start of the infusion) was significantly correlated with, and not statistically different from, actual values as follows: AUC0–∞ = 2556.5 C6 + 320.9 (r2 = 0.929, P 0–∞, suggesting that this time-point is acceptable for busulfan monitoring.

Original languageEnglish
Pages (from-to)611-616
Number of pages6
JournalInternational Journal of Hematology
Volume102
Issue number5
DOIs
Publication statusPublished - 2015 Aug 5
Externally publishedYes

Fingerprint

Busulfan
Hematopoietic Stem Cells
Pediatrics
Transplants
Pharmaceutical Preparations
Hematopoietic Stem Cell Transplantation
Area Under Curve
Transplant Recipients
Linear Models
Pharmacokinetics

Keywords

  • Busulfan
  • Children
  • Hematopoietic stem cell transplantation
  • Limited sampling strategy
  • Pharmacokinetics

ASJC Scopus subject areas

  • Hematology

Cite this

Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients. / Watanabe, Erika; Nishikawa, Takuro; Ikawa, Kazuro; Yamaguchi, Hiroki; Abematsu, Takanari; Nakagawa, Shunsuke; Kurauchi, Koichiro; Kodama, Yuichi; Tanabe, Takayuki; Shinkoda, Yuichi; Matsumoto, Kazuaki; Okamoto, Yasuhiro; Takeda, Yasuo; Kawano, Yoshifumi.

In: International Journal of Hematology, Vol. 102, No. 5, 05.08.2015, p. 611-616.

Research output: Contribution to journalArticle

Watanabe, E, Nishikawa, T, Ikawa, K, Yamaguchi, H, Abematsu, T, Nakagawa, S, Kurauchi, K, Kodama, Y, Tanabe, T, Shinkoda, Y, Matsumoto, K, Okamoto, Y, Takeda, Y & Kawano, Y 2015, 'Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients', International Journal of Hematology, vol. 102, no. 5, pp. 611-616. https://doi.org/10.1007/s12185-015-1853-6
Watanabe, Erika ; Nishikawa, Takuro ; Ikawa, Kazuro ; Yamaguchi, Hiroki ; Abematsu, Takanari ; Nakagawa, Shunsuke ; Kurauchi, Koichiro ; Kodama, Yuichi ; Tanabe, Takayuki ; Shinkoda, Yuichi ; Matsumoto, Kazuaki ; Okamoto, Yasuhiro ; Takeda, Yasuo ; Kawano, Yoshifumi. / Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients. In: International Journal of Hematology. 2015 ; Vol. 102, No. 5. pp. 611-616.
@article{76b3e7a049e248398e90bd590125b828,
title = "Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients",
abstract = "Optimizing systemic busulfan exposure, the area under the concentration–time curve (AUC), improves the outcomes for hematopoietic stem cell transplantation (HSCT). The AUC is conventionally calculated using six plasma concentrations (AUC0–∞) drawn after the first of 16 intravenous busulfan doses given as a 2-h infusion every 6 h. The aim of the present study was to develop limited sampling strategies using three or fewer busulfan concentrations to reliably calculate AUC0–∞ in patients undergoing HSCT. We investigated the pharmacokinetics of busulfan 46 times in 29 pediatric patients receiving intravenous busulfan. Limited sampling strategies using one, two, or three plasma busulfan concentrations were developed by multiple linear regression that showed excellent agreement with AUC0–∞. In single-point sampling strategies, the AUC0–∞ predicted based on C6 (trough level: busulfan plasma concentration 6 h after the start of the infusion) was significantly correlated with, and not statistically different from, actual values as follows: AUC0–∞ = 2556.5 C6 + 320.9 (r2 = 0.929, P 0–∞, suggesting that this time-point is acceptable for busulfan monitoring.",
keywords = "Busulfan, Children, Hematopoietic stem cell transplantation, Limited sampling strategy, Pharmacokinetics",
author = "Erika Watanabe and Takuro Nishikawa and Kazuro Ikawa and Hiroki Yamaguchi and Takanari Abematsu and Shunsuke Nakagawa and Koichiro Kurauchi and Yuichi Kodama and Takayuki Tanabe and Yuichi Shinkoda and Kazuaki Matsumoto and Yasuhiro Okamoto and Yasuo Takeda and Yoshifumi Kawano",
year = "2015",
month = "8",
day = "5",
doi = "10.1007/s12185-015-1853-6",
language = "English",
volume = "102",
pages = "611--616",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients

AU - Watanabe, Erika

AU - Nishikawa, Takuro

AU - Ikawa, Kazuro

AU - Yamaguchi, Hiroki

AU - Abematsu, Takanari

AU - Nakagawa, Shunsuke

AU - Kurauchi, Koichiro

AU - Kodama, Yuichi

AU - Tanabe, Takayuki

AU - Shinkoda, Yuichi

AU - Matsumoto, Kazuaki

AU - Okamoto, Yasuhiro

AU - Takeda, Yasuo

AU - Kawano, Yoshifumi

PY - 2015/8/5

Y1 - 2015/8/5

N2 - Optimizing systemic busulfan exposure, the area under the concentration–time curve (AUC), improves the outcomes for hematopoietic stem cell transplantation (HSCT). The AUC is conventionally calculated using six plasma concentrations (AUC0–∞) drawn after the first of 16 intravenous busulfan doses given as a 2-h infusion every 6 h. The aim of the present study was to develop limited sampling strategies using three or fewer busulfan concentrations to reliably calculate AUC0–∞ in patients undergoing HSCT. We investigated the pharmacokinetics of busulfan 46 times in 29 pediatric patients receiving intravenous busulfan. Limited sampling strategies using one, two, or three plasma busulfan concentrations were developed by multiple linear regression that showed excellent agreement with AUC0–∞. In single-point sampling strategies, the AUC0–∞ predicted based on C6 (trough level: busulfan plasma concentration 6 h after the start of the infusion) was significantly correlated with, and not statistically different from, actual values as follows: AUC0–∞ = 2556.5 C6 + 320.9 (r2 = 0.929, P 0–∞, suggesting that this time-point is acceptable for busulfan monitoring.

AB - Optimizing systemic busulfan exposure, the area under the concentration–time curve (AUC), improves the outcomes for hematopoietic stem cell transplantation (HSCT). The AUC is conventionally calculated using six plasma concentrations (AUC0–∞) drawn after the first of 16 intravenous busulfan doses given as a 2-h infusion every 6 h. The aim of the present study was to develop limited sampling strategies using three or fewer busulfan concentrations to reliably calculate AUC0–∞ in patients undergoing HSCT. We investigated the pharmacokinetics of busulfan 46 times in 29 pediatric patients receiving intravenous busulfan. Limited sampling strategies using one, two, or three plasma busulfan concentrations were developed by multiple linear regression that showed excellent agreement with AUC0–∞. In single-point sampling strategies, the AUC0–∞ predicted based on C6 (trough level: busulfan plasma concentration 6 h after the start of the infusion) was significantly correlated with, and not statistically different from, actual values as follows: AUC0–∞ = 2556.5 C6 + 320.9 (r2 = 0.929, P 0–∞, suggesting that this time-point is acceptable for busulfan monitoring.

KW - Busulfan

KW - Children

KW - Hematopoietic stem cell transplantation

KW - Limited sampling strategy

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=84947016753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947016753&partnerID=8YFLogxK

U2 - 10.1007/s12185-015-1853-6

DO - 10.1007/s12185-015-1853-6

M3 - Article

C2 - 26243625

AN - SCOPUS:84947016753

VL - 102

SP - 611

EP - 616

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 5

ER -